Neon Financial Statements From 2010 to 2025
| NBCO Stock | USD 0.02 0.0005 2.44% |
Check Neon Bloom financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Neon Bloom's main balance sheet or income statement drivers, such as , as well as many indicators such as . Neon financial statements analysis is a perfect complement when working with Neon Bloom Valuation or Volatility modules.
Neon |
Neon Bloom Company Return On Equity Analysis
Neon Bloom's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Neon Bloom Return On Equity | -0.41 |
Most of Neon Bloom's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Neon Bloom is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Neon Bloom has a Return On Equity of -0.4121. This is 98.28% lower than that of the Healthcare sector and 98.87% lower than that of the Biotechnology industry. The return on equity for all United States stocks is 32.94% higher than that of the company.
Neon Bloom Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Neon Bloom's current stock value. Our valuation model uses many indicators to compare Neon Bloom value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Neon Bloom competition to find correlations between indicators driving Neon Bloom's intrinsic value. More Info.Neon Bloom is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in operating margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Neon Bloom by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Neon Bloom's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Neon Bloom Financial Statements
Neon Bloom investors utilize fundamental indicators, such as revenue or net income, to predict how Neon Pink Sheet might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Neon Bloom, Inc. is a principal investment firm specializing in acquisitions. Neon Bloom, Inc was founded in 2015 and is based in New York, New York. Neon Bloom operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 2 people.
Other Information on Investing in Neon Pink Sheet
Neon Bloom financial ratios help investors to determine whether Neon Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Neon with respect to the benefits of owning Neon Bloom security.